Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1978 Mar;90(3):565–581.

Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines.

G D Sorenson, O S Pettengill, C C Cate
PMCID: PMC2018238  PMID: 629324

Abstract

Murine plasmacytoma cells gradually decrease in oncogenicity with prolonged culture in vitro. Newly established cultures are oncogenic and cause lethal tumors. Subsequently, the cultures are oncogenic but some of the tumors regress. Later in the life of the culture none of the tumors are lethal. The longer the cells are in culture, the less oncogenic they become; eventually the cultures are nononcogenic in normal mice but do cause tumors in irradiated mice. Clones from the cultures vary from being very oncogenic to being nononcogenic. It appears that the nononcogenic cells have a selective growth advantage and become the dominant cell type in the cultures. Nononcogenic cultures are more effective for immunization to subsequent challenge with the original tumor than are the tumor cells or oncogenic cultures and may confer complete protection against lethal tumor challenge in adoptive transfer experiments. Mixtures of nononcogenic and oncogenic cells decrease the tumor-forming ability of the latter when they are injected together in one site or injected separately in two sites.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbieri D., Belehradek J., Jr, Barski G. Decrease in tumor-producing capacity of mouse cell lines following infection with mouse leukemia viruses. Int J Cancer. 1971 Mar 15;7(2):364–371. doi: 10.1002/ijc.2910070222. [DOI] [PubMed] [Google Scholar]
  2. Borek C., Sachs L. In vitro cell transformation by x-irradiation. Nature. 1966 Apr 16;210(5033):276–278. doi: 10.1038/210276a0. [DOI] [PubMed] [Google Scholar]
  3. Boyer P. J., Fahey J. L. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors. J Immunol. 1976 Jan;116(1):202–209. [PubMed] [Google Scholar]
  4. Coffino P., Baumal R., Laskov R., Scharff M. D. Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol. 1972 Jun;79(3):429–440. doi: 10.1002/jcp.1040790313. [DOI] [PubMed] [Google Scholar]
  5. Cohen J. M., Law L. W. Spontaneous disappearance of tumorigenicity in a polyoma virus-induced neoplasm carried in vitro. Proc Soc Exp Biol Med. 1974 Feb;145(2):385–388. doi: 10.3181/00379727-145-37815. [DOI] [PubMed] [Google Scholar]
  6. DAWE C. J., POTTER M., LEIGHTON J. Progressions of a reticulum-cell sarcoma of the mouse in vivo and in vitro. J Natl Cancer Inst. 1958 Oct;21(4):753–781. [PubMed] [Google Scholar]
  7. DE BRUYN W. M., GEY G. O. Further studies in vitro of transplantable mouse lymphosarcoma MB (T 86157). Acta Unio Int Contra Cancrum. 1952;7(5):772–775. [PubMed] [Google Scholar]
  8. Diamond L. The interaction of chemical carcinogens and cells in vitro. Prog Exp Tumor Res. 1969;11:364–383. doi: 10.1159/000391402. [DOI] [PubMed] [Google Scholar]
  9. EARLE W. R., SHELTON E., SCHILLING E. L. Production of malignancy in vitro. XI. Further results from reinjection of in vitro cell strains into strain C3H mice. J Natl Cancer Inst. 1950 Apr;10(5):1105–1113. [PubMed] [Google Scholar]
  10. EVANS V. J., HAWKINS N. M., WESTFALL B. B., EARLE W. R. Studies on culture lines derived from mouse liver parenchymatous cells grown in long-term tissue culture. Cancer Res. 1958 Apr;18(3):261–266. [PubMed] [Google Scholar]
  11. FOLEY G. E., DROLET B. P. LOSS OF NEOPLASTIC PROPERTIES IN VITRO. I. OBSERVATIONS WITH S-180 CELL LINES. Cancer Res. 1964 Sep;24:1461–1467. [PubMed] [Google Scholar]
  12. HSU T. C. Reduction of transplantability of Novikoff hepatoma cells grown in vitro and the consequent protecting effect to the host against their malignant progenitor. J Natl Cancer Inst. 1960 Nov;25:927–935. [PubMed] [Google Scholar]
  13. Jurin M. Loss and recovery of transplantability of L-P59 cells. In Vitro. 1973 Mar-Apr;8(5):379–382. doi: 10.1007/BF02619064. [DOI] [PubMed] [Google Scholar]
  14. Kieler J., Radzikowski C., Moore J., Ulrich K. Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro. J Natl Cancer Inst. 1972 Feb;48(2):393–405. [PubMed] [Google Scholar]
  15. Lespinats G. Induction d'une immunité vis-à-vis de la greffe de plasmocytosarcomes chez la souris BALB-c. Eur J Cancer. 1969 Nov;5(5):421–426. doi: 10.1016/0014-2964(69)90095-4. [DOI] [PubMed] [Google Scholar]
  16. Marin G., MacPherson I. Reversion in polyoma-transformed cells: retransformation, induced antigens and tumorigenicity. J Virol. 1969 Feb;3(2):146–149. doi: 10.1128/jvi.3.2.146-149.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McAllister R. M., Reed G. Colonial growth in agar of cells derived from neoplastic and non-neoplastic tissues of children. Pediatr Res. 1968 Sep;2(5):356–360. doi: 10.1203/00006450-196809000-00004. [DOI] [PubMed] [Google Scholar]
  18. Meyer G. Viral genome and oncogenic transformation: nuclear and plasma membrane events. Adv Cancer Res. 1971;14:71–159. doi: 10.1016/s0065-230x(08)60519-9. [DOI] [PubMed] [Google Scholar]
  19. Moore J., Kieler J., Biczowa B. Comparative studies of a near-tetraploid and a near-diploid line of Ehrlich's ascites tumor propagated in vivo and in vitro. II. Cytology and transplantability. Eur J Cancer. 1968 Mar;4(1):81–95. doi: 10.1016/0014-2964(68)90072-8. [DOI] [PubMed] [Google Scholar]
  20. Morgan J. F., Eng C. P., Heuchert M. D., Kirk H. D. Loss of transplantability and induction of immunoprotection by mouse ascites tumor cells in tissue culture. Proc Soc Exp Biol Med. 1970 May;134(1):305–308. doi: 10.3181/00379727-134-34782. [DOI] [PubMed] [Google Scholar]
  21. Morgan J. F., Eng C. P. The induction of immunoprotection by mouse ascites tumor cells attenuated in tissue culture. Eur J Cancer. 1972 Jun;8(3):293–298. doi: 10.1016/0014-2964(72)90023-0. [DOI] [PubMed] [Google Scholar]
  22. Pettengill O. S., Sorenson G. D. Growth characteristics of long-term cultures of mouse myeloma cells. Exp Cell Res. 1972 Jan;70(1):65–72. doi: 10.1016/0014-4827(72)90182-6. [DOI] [PubMed] [Google Scholar]
  23. Potter M., Pumphrey J. G., Walters J. L. Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J Natl Cancer Inst. 1972 Jul;49(1):305–308. [PubMed] [Google Scholar]
  24. Rabinowitz Z., Sachs L. The formation of variants with a reversion of properties of transformed cells. IV. Loss of detectable polyoma transplantation antigen. Virology. 1970 Feb;40(2):193–198. doi: 10.1016/0042-6822(70)90394-6. [DOI] [PubMed] [Google Scholar]
  25. Röllinghoff M., Rouse B. T., Warner N. L. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors. J Natl Cancer Inst. 1973 Jan;50(1):159–172. doi: 10.1093/jnci/50.1.159. [DOI] [PubMed] [Google Scholar]
  26. SANFORD K. K., MERWIN R. M., HOBBS G. L., FIORAMONTI M. C., EARLE W. R. Studies on the difference in sarcoma-producing capacity of two lines of mouse cells derived in vitro from one cell. J Natl Cancer Inst. 1958 Jan;20(1):121–145. [PubMed] [Google Scholar]
  27. Sanford K. K. Malignant transformation of cells in vitro. Int Rev Cytol. 1965;18:249–311. doi: 10.1016/s0074-7696(08)60556-2. [DOI] [PubMed] [Google Scholar]
  28. Shin H. S., Pasternack G. R., Economou J. S., Johnson R. J., Hayden M. L. Immunotherapy of cancer with antibody. Science. 1976 Oct 15;194(4262):327–329. doi: 10.1126/science.989623. [DOI] [PubMed] [Google Scholar]
  29. Silagi S., Newcomb E. W., Weksler M. E. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity. Cancer Res. 1974 Jan;34(1):100–104. [PubMed] [Google Scholar]
  30. Sorenson G. D., Pettengill O. S. Morphologic and functional characteristics of long-term cultures of murine myeloma cells. Am J Pathol. 1972 May;67(2):241–264. [PMC free article] [PubMed] [Google Scholar]
  31. Williams W. H., Krueger R. G. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice. J Natl Cancer Inst. 1972 Dec;49(6):1613–1620. doi: 10.1093/jnci/49.6.1613. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES